Mereo BioPharma (MREO) Interest Coverage Ratio (2023 - 2026)
Mereo BioPharma (MREO) posted quarterly Interest Coverage Ratio of 42.55 for Q1 2026, up 27.06% year-on-year from 33.49 in Q1 2025, and down 191.64% on a QoQ basis from 14.59 in Q4 2025.
Mereo BioPharma (MREO) Interest Coverage Ratio (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Interest Coverage Ratio for 4 consecutive years, with 42.55 the latest figure, recorded in Q1 2026.
- Quarterly Interest Coverage Ratio rose 27.06% year-over-year to 42.55 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 27.95 (up 83.29% YoY) and the FY2025 annual result came in at 0.18, up 19.71% from the prior year.
- Interest Coverage Ratio fell to 42.55 in Q1 2026 per MREO's latest filing, from 14.59 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for MREO reached as high as 12.16 in Q4 2023 and fell as low as 58.34 in Q1 2025.
- A 4-year average of 16.01 and a median of 12.95 in 2023 frame the typical range for Interest Coverage Ratio.
- The largest YoY upside for Interest Coverage Ratio was 96.97% in 2024 against a maximum downside of 434.87% in 2024.
- Year by year, Interest Coverage Ratio stood at 12.16 in 2023, then slumped by 434.87% to 40.73 in 2024, then soared by 64.18% to 14.59 in 2025, then slumped by 191.64% to 42.55 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 42.55, 14.59, and 2.07 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Mereo BioPharma | 232.52 Mn | 232.52 Mn | - | -42.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.55 |
| Dec 31, 2025 | -14.59 |
| Sep 30, 2025 | -2.07 |
| Jun 30, 2025 | -1.04 |
| Mar 31, 2025 | -58.34 |
| Dec 31, 2024 | -40.73 |
| Sep 30, 2024 | -0.39 |
| Jun 30, 2024 | -0.68 |
| Mar 31, 2024 | -31.94 |
| Dec 31, 2023 | 12.16 |
| Sep 30, 2023 | -12.95 |
| Jun 30, 2023 | -0.79 |
| Mar 31, 2023 | -14.26 |